The purpose of this study is to compare the effects, good and/or bad, of abiraterone, prednisone, and enzalutamide with enzalutamide alone on you and your prostate cancer to find out which is better.
Leslie Howard, MD
This randomized phase III trial studies lenalidomide, dexamethasone, and bortezomib to see how well it works compared to dexamethasone and lenalidomide alone in treating patients with previously untreated multiple myeloma. Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, such as dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the cancer. It is not yet known whether lenalidomide and dexamethasone is more effective with or without bortezomib in treating multiple myeloma.
Syed Ali, MD
Cancer - Leukemia,
Cancer
D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
The purpose of this study is to compare standard treatment, radiation therapy combined with the chemotherapy drug cisplatin, to standard chemo-radiation therapy plus additional experimental chemotherapy to see if it reduces the risk of tumor recurrence and improves overall survival.
Tashanna Myers, MD
Cancer-Gynecologic,
Cancer
D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
Seth Kaufman, MD
Cancer - Esophogus,
Cancer
D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
Page 1 of 4 | Results 1 - 10 of 40